MarkASchattnerMD
Gastroenterology • New York, NYAdvanced Endoscopic Interventional
Associate Professor, Medicine, Weill Cornell Medical College
Overview of Dr. Schattner
Dr. Mark Schattner is a gastroenterologist in New York, NY and is affiliated with Memorial Sloan Kettering Cancer Center. He received his medical degree from Perelman School of Medicine at the University of Pennsylvania and has been in practice 22 years. Dr. Schattner accepts several types of health insurance, listed below. He is one of 35 doctors at Memorial Sloan Kettering Cancer Center who specialize in Gastroenterology. He has more than 100 publications and over 500 citings.
Office
160 East 53rd Street
New York, NY 10022
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Gastroenterology, 1999 - 2002
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1995 - 1998
Perelman School of Medicine at the University of PennsylvaniaClass of 1995
Certifications & Licensure
FL State Medical License 2021 - Present
NY State Medical License 1996 - 2026
NJ State Medical License 2017 - 2025- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
Clinical Trials
- Endoscopic Biliary Co-axial Stent Placement Plus/Minus Use of Radiofrequency Ablation (RFA) for Clearance of Occluded Self Expandable Metal Stents (SEMS) in Patients With Distal Biliary Obstruction From Unresectable Biliary-pancreatic Malignancies Start of enrollment: 2015 Jan 01
- Pancrelipase in People With Pancreatic Ductal Adenocarcinoma (PDAC) Start of enrollment: 2022 Nov 30
Roles: Contact
Publications & Presentations
PubMed
- 98 citationsCyst Fluid Interleukin-1β (IL1β) Levels Predict the Risk of Carcinoma in Intraductal Papillary Mucinous Neoplasms of the PancreasAjay V. Maker, Nora Katabi, Li-Xuan Qin, David S. Klimstra, Mark A. Schattner
Clinical Cancer Research. 2011-03-15 - 2 citationsFactors associated with detection of hereditary diffuse gastric cancer on endoscopy in individuals with germline CDH1 mutations.Monika Laszkowska, Laura Tang, Elvira Vos, Stephanie King, Erin Salo-Mullen
Gastrointestinal Endoscopy. 2023-09-01 - 32 citationsIndications for Total Gastrectomy in CDH1 Mutation Carriers and Outcomes of Risk-Reducing Minimally Invasive and Open Gastrectomies.Elvira L. Vos, Erin E. Salo-Mullen, Laura H. Tang, Mark A. Schattner, Sam S. Yoon
JAMA Surgery. 2020-11-01
Authored Content
- Tu1435 ENDOSCOPIC BILIARY STENTING FOR MALIGNANT BILIARY OBSTRUCTION IS TECHNICALLY SUCCESSFUL IN PATIENTS WITH PRE- EXISTING DUODENAL STENTSMay 2018
- Tu1435 ENDOSCOPIC BILIARY STENTING FOR MALIGNANT BILIARY OBSTRUCTION IS TECHNICALLY SUCCESSFUL IN PATIENTS WITH PRE- EXISTING DUODENAL STENTSMay 2018
- Predictors of Clinical Outcome of Colonic Stents in Patients with Malignant Large-Bowel Obstruction Due to Extracolonic MalignancyJanuary 2018
Press Mentions
Treatment of Esophageal/Gastroesophageal Junction Adenocarcinoma in Patients with History of Prior Bariatric SurgeryMay 7th, 2023
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Empire BCBS HMO
Empire BCBS PPO
GHI PPO
Great West PPOHumana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
MVP Healthcare PPO
Oxford Health Freedom
Oxford Health Liberty
QualCare HMO
QualCare PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
